Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PLATINUM Diversity: Outcomes With the Promus PREMIER Stent in Women and Minorities (S2326)

Next Previous
Search
Trial Profile

PLATINUM Diversity: Outcomes With the Promus PREMIER Stent in Women and Minorities (S2326)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Mar 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms PLATINUM Diversity
  • Sponsors Boston Scientific Corporation

    • Most Recent Events

    • 23 Feb 2021 Results (n=4184) of pooled analysis of two studies (Platinum Diversity (PD) and Promus Element Plus (PE Plus)), published in the American Heart Journal.
    • 18 Nov 2019 Results of pooled analysis from the Platinum diversity and Promus element plus post approval studies evaluating the incidence of DAPT cessation during the first year after PCI in men and women and its association with clinical outcomes presented at the American Heart Association Scientific Sessions 2019
    • 19 May 2017 According to a Boston Scientific Corporation media release, New data from this study was presented at the 40th Annual Society for Cardiac Angiography and Interventions (SCAI) Scientific Sessions.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top